Mast Therapeutics, Inc.'s ticker is and the CUSIP is 057631410. A total of 1 filers reported holding Mast Therapeutics, Inc. in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $1,887,000 | – | 3,000,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 3,000,000 | $1,887,000 | 0.02% |